These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I]. Wang R, Li X, Qian M, Niu J, You Z. Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412 [Abstract] [Full Text] [Related]
45. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value. Cho NH, Lim SY, Kim YT, Kim D, Kim YS, Kim JW. Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336 [Abstract] [Full Text] [Related]
50. Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression. Gupta R, Srinivasan R, Nijhawan R, Suri V. Virchows Arch; 2010 Jan; 456(1):45-51. PubMed ID: 19937343 [Abstract] [Full Text] [Related]
51. The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions. Lin Z, Gao M, Zhang X, Kim YS, Lee ES, Kim HK, Kim I. J Cancer Res Clin Oncol; 2005 Jun; 131(6):364-70. PubMed ID: 15785933 [Abstract] [Full Text] [Related]
54. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China. Liao GD, Sellors JW, Sun HK, Zhang X, Bao YP, Jeronimo J, Chen W, Zhao FH, Song Y, Cao Z, Zhang SK, Xi MR, Qiao YL. Int J Cancer; 2014 Apr 01; 134(7):1715-24. PubMed ID: 24105727 [Abstract] [Full Text] [Related]